API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
API
USP / EP / In-house Pharmaceutical Grade
C12H9N3O5S
2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide
55981-09-4
307.28 g/mol
Antiprotozoal / Antiviral / Anthelmintic – Thiazolide Derivative
| Appearance | Yellow crystalline powder |
|---|---|
| Solubility | Practically insoluble in water; soluble in DMSO, acetone, and ethanol; slightly soluble in alkaline solutions |
| Melting point | 205–210°C |
| pH | Approximately neutral (depends on formulation excipients) |
Nitazoxanide is a broad-spectrum antiprotozoal and antiviral Active Pharmaceutical Ingredient (API) widely used for intestinal parasitic infections and viral gastroenteritis. It is effective against Giardia lamblia, Cryptosporidium parvum, helminths, anaerobic bacteria, and several viruses including rotavirus and norovirus. Its excellent safety profile makes it suitable for both adults and children.
Nitazoxanide blocks pyruvate:ferredoxin oxidoreductase (PFOR)-dependent electron transfer reactions, disrupting anaerobic energy metabolism in protozoa and some bacteria. It also inhibits viral protein maturation in certain viruses, preventing replication and survival.
| Attribute | Why Salius Pharma Is a Good Choice |
|---|---|
| Quality Certification | WHO GMP, ISO 9001:2015, FDA audited facilities |
| Affordability & Generic Access | Cost competitive generics for global supply |
| Export Experience | Proven track record of supplying globally |
When you order from Salius Pharma, you receive more than just a product — you receive a complete, professionally prepared package that meets international regulatory and quality expectations.
We ensure prompt and reliable shipping worldwide. Delivery times vary depending on destination, order volume, and regulatory requirements.
7 to 21 business days from dispatch, depending on your location.
Nitazoxanide is used to treat protozoal infections such as Giardia and Cryptosporidium, as well as helminths, anaerobic bacteria, and certain viral infections like rotavirus and norovirus. It is suitable for both adults and children.
Yes. Nitazoxanide inhibits viral protein maturation and replication. It has been studied for use against rotavirus, norovirus, hepatitis C, influenza, and other viral infections.
Quality tests include Identity (IR/HPLC), Assay, Related impurities, Loss on drying, Residual solvents, Microbial limits, and Particle size distribution.
Salius Pharma exports to Asia (India, Bangladesh, Sri Lanka), the Middle East, Africa, CIS, and Latin America — regions with high protozoal infection prevalence.
Orders are typically dispatched within 7–14 business days, depending on quantity and documentation requirements.
It inhibits maturation of viral proteins, reducing replication of rotavirus and norovirus, thereby helping to manage acute viral gastroenteritis effectively.
Looking to source Nitazoxanide or other high-quality pharmaceutical products?
We’re here to help.
Whether you need Active Pharmaceutical Ingredients (APIs), finished formulations, or regulatory support,
our team is ready to provide dependable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.